Brainsway
Brainsway is the developer of Deep Transcranial Magnetic Stimulation (TMS) Therapy, a patented, noninvasive, FDA-cleared solution for treating depressive episodes in adult patients suffering from major depressive disorder who have failed to achieve s.
Launch date
Employees
Market cap
AUD198m
Enterprise valuation
AUD128m (Public information from Sep 2024)
Share price
$8.19 BWAY
Burlington Massachusetts (HQ)
Authorizing premium user...